Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells

Kidney International

Volumn 71, Issue 8, 2007, Pages 738-743

  Nii Kono, T ^a   Iwasaki, Y ^b   Uchida, M ^c   Fujieda, A ^c   Hosokawa, A ^c   Motojima, M ^d   Yamato, H ^c   Kurokawa, K ^e   Fukagawa, M ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

^c KUREHA CORPORATION   (Japan)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; FREE RADICAL; INDICAN; ORGANIC ANION TRANSPORTER 3; PARATHYROID HORMONE; UREMIC TOXIN;

ANIMAL CELL; ARTICLE; CALVARIA; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; HORMONE RESISTANCE; MOUSE; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PARATHYROID HORMOME RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

ANIMALS; BONE AND BONES; CELL SURVIVAL; CELLS, CULTURED; FEMALE; GENE EXPRESSION; INDICAN; MICE; ORGANIC ANION TRANSPORTERS; OSTEOBLASTS; OXIDATIVE STRESS; PARATHYROID HORMONE; PREGNANCY;

EID: 34247219265     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002097     Document Type: Article

References (36)

1. Almanden Y, Canalejo A, Hernandez A et al. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 1996; 11: 970-976.
2. Tatsumi S, Miyamato K, Takeda E et al. Molecular cloning and hormonal regulation of Pit-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands. Endocrinology 1998; 139: 1692-1699.
3. Fukagawa M, Akizawa T, Kurokawa K. Is aplastic osteodystrophy a disease of malnutrition? Curr Opin Nephrol Hypertens 2000; 9: 363-367.
4. Picton ML, Moore PR, Mawer B et al. Down-regulation of human osteoblast PTH/PTHrP receptor in end-stage renal failure. Kidney Int 2000; 58: 1440-1449.
5. Slatopolsky E, Finch J, Clay P et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000; 58: 753-761.
6. Gao P, Sheibel S, D'Amoour P et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J bone Miner Res 2001; 16: 605-614.
7. Kazama JJ, Shigematsu T, Yano K et al. Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 2002; 39: 525-532.
8. Gonnelli S, Montagnani A, Caffarelli C et al. Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis. J Endocrinol Invest 2005; 28: 534-539.
9. Coen G, Ballanti P, Balucci A et al. Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant 2002; 17: 233-238.
10. Hruska K. New concepts in renal osteodystrophy. Nephrol Dial Transplant 1998; 13: 2755-2760.
11. Iwasaki-Ishizuka Y, Yamato H, Nii-Kohno T et al. Down-regulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 2005; 20: 1904-1911.
12. Niwa T, Takeda N, Tatematsu A et al. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem 1988; 34: 2264-2267.
13. Niwa T, Nomura T, Sugano M et al. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron 1991; 57: 84-88.
14. Niwa T, Aoyama I, Takayama F et al. Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure. Miner Electrolyte Metab 1999; 25: 118-122.
15. Motojima M, Hosokawa A, Yamato H et al. Uremic toxins proximal tubular injury via organic anion transpoter-1-mediated uptake. Br J Pharmacol 2002; 135: 555-563.
16. Enomoto A, Takeda M, Tojo A et al. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 2002; 13: 1711-1720.
17. Motojima M, Hosokawa A, Yamato H et al. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kB and free radical in proximal tubular cells. Kidney Int 2003; 63: 1671-1680.
18. Deguchi T, Kusuhara H, Takedate A et al. Characterization of uremic toxin transport by organic anion transporters in kidney. Kidney Int 2004; 65: 162-174.
19. Deguchi T, Kouno Y, Terasaki T et al. Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats. Pharm Res 2005; 22: 619-627.
20. Niwa T, Nomura T, Sugiyama S et al. The protein metabolite hypothesis, a model for the progression of renal failure: an oral sorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int 1997; 62(Suppl 62): S23-S28.
21. Tsubakihara Y, Takabatake Y, Oka K et al. Effect of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients. Am Kidney Dis 2003; 41(3 Suppl 1): S38-S41.
22. Yorioka N, Ito T, Masaki T et al. Dose-dependent effect of an oral absorbent AST-120, in patients with early chronic renal failure. J Int Med Res 2002; 30: 467-475.
23. Iwasaki Y, Yamato H, Nii-Kono T et al. Administration of oral absorbent (AST-120) suppressed low-turnover bone progression in ureamic rats. Nephrol Dial Transplant 2006; 21: 2768-2774.
24. Gelasco AK, Raymond JR. Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Renal Physiol 2006; 290: 1551-1558.
25. Bai XC, Lu D, Bai J et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappa B. Biochem Biophys Res Commun 2004; 314: 197-207.
26. Mody N, Parhami F, Sarafian TA et al. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001; 31: 509-519.
27. 2-derived free radicals treated fibronectin substratum reduces the bone nodule formation of rat calvarial osteoblast. Mech Ageing Dev 1997; 98: 113-125.
28. Sun JS, Tsuang YH, Huang WC et al. Menadione-induced cytotoxicity to rat osteoblasts. Cell Mol Life Sci 1997; 53: 967-976.
29. Vanholder R, Smet RD, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
30. Disthabanchong S, Hassan H, Charles L et al. Regulation of PTH 1 receptor expression by uremic ultrafiltrate in UMR-106-01 osteoblast-like cells. Kidney Int 2004; 65: 897-903.
31. Steddon SJ, Mclntyre CW, Schroeder NL, et al. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu. Nephrol Dial Transplant 2004; 19: 3078-3083.
32. Uchida M, Shima M, Shimoaka T et al. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol 2000; 185: 207-214.
33. Sweet DH, Miller DS, Pritchard JB et al. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 2002; 277: 26934-26943.
34. Nesbitt T, Fujiwara I, Thomas R et al. Coordinated maturational regulation of PHEX and renal phosphate transport inhibitory activity: evidence for the pathophysiological role of PHEX in X-linked hypophosphatemia. J Bone Miner Res 1999; 14: 2027-2035.
35. Motojima M, Nishijima F, Ikoma M et al. Role for 'uremic toxin' in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991; 40: 461-469.
36. McCormic ML, Denning GM, Reszka KJ et al. Biological effects of menadione photochemistry: effect of menadione on biological systems may not involve classical oxidant production. Biochem J 2000; 350: 797-804.